Tingbo Liu

430 total citations
49 papers, 306 citations indexed

About

Tingbo Liu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tingbo Liu has authored 49 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 17 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Tingbo Liu's work include Lymphoma Diagnosis and Treatment (19 papers), Acute Myeloid Leukemia Research (8 papers) and Viral-associated cancers and disorders (6 papers). Tingbo Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Acute Myeloid Leukemia Research (8 papers) and Viral-associated cancers and disorders (6 papers). Tingbo Liu collaborates with scholars based in China, United States and Japan. Tingbo Liu's co-authors include Jianda Hu, Yingyu Chen, Zhi‐Hong Zheng, Jie Pan, Lili Pan, Lihong Chen, Zhihong Zheng, Jing Zheng, Jing Li and Xinji Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tingbo Liu

42 papers receiving 304 citations

Peers

Tingbo Liu

ONCOL

HEMAT

PFM

Shan Meng China

V. Nüßler Germany

Girija Ramaswamy India

Laura M. Popoviciu United States

Irene Luna Spain

Noushin Heidary United States

Yoko Inaguma Japan

Chenying Li China

R Abele Switzerland

Shan Meng China

Tingbo Liu

196 ×1.5

95 ×1.1

ONCOL

108 ×1.5

HEMAT

31 ×0.6

PFM

40 ×1.1

Citations per year, relative to Tingbo Liu Tingbo Liu (= 1×) peers Shan Meng

Countries citing papers authored by Tingbo Liu

Since Specialization

Citations

This map shows the geographic impact of Tingbo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingbo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingbo Liu more than expected).

Fields of papers citing papers by Tingbo Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingbo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingbo Liu. The network helps show where Tingbo Liu may publish in the future.

Co-authorship network of co-authors of Tingbo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Tingbo Liu. A scholar is included among the top collaborators of Tingbo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingbo Liu. Tingbo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yanyan, Yanyan Qiu, Hao Zheng, et al.. (2025). Rethinking bone marrow biopsy: is PET/CT enough for staging low-grade follicular lymphomas?. Annals of Hematology. 104(7). 3791–3801.

Yang, Yong, et al.. (2025). Next-generation sequencing of circulating tumor DNA in cerebrospinal fluid for detecting gene mutations in central nervous system lymphoma patients. Therapeutic Advances in Hematology. 16. 1584239481–1584239481. 1 indexed citations

Wang, Xun, et al.. (2025). Comparing surgical and conservative treatment approaches for perianal abscess in patients with hematologic malignancies: a comprehensive analysis. BMC Gastroenterology. 25(1). 246–246.

Huang, Ling, Tingbo Liu, Zhigang Peng, et al.. (2025). Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China. Frontiers in Oncology. 15. 1580370–1580370.

Zhuang, Quan‐Quan, Yue Liu, Huanhuan Sun, et al.. (2023). Synthetic Antibacterial Quaternary Phosphorus Salts Promote Methicillin-Resistant Staphylococcus aureus-Infected Wound Healing. International Journal of Nanomedicine. Volume 18. 1145–1158. 15 indexed citations

Shen, Jianzhen, et al.. (2023). Diagnostic and Prognostic Evaluation Value of 18f-FDG PET-CT for Bone Marrow Infiltration in Primary Treated Follicular Lymphoma. Blood. 142(Supplement 1). 6154–6154.

Zhao, Ruizhi, S. Han, Yanyan Qiu, et al.. (2023). The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors. SHILAP Revista de lepidopterología. 4(1). 86–92. 3 indexed citations

Chen, Dongxu, et al.. (2022). Dynamic Prediction of Survival for Sinonasal Extranodal Natural Killer/T‐cell Lymphoma. The Laryngoscope. 133(7). 1645–1651. 1 indexed citations

Liu, Tingbo, et al.. (2021). 肌球蛋白轻链9在恶性肿瘤中的研究进展. PubMed Central. 1 indexed citations

10.

Zhou, Huarong, Yanyan Qiu, Jianfei Wang, et al.. (2021). SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas. Frontiers in Oncology. 11. 765544–765544. 4 indexed citations

11.

Chen, Yi, Hong Chen, Zhihong Zheng, et al.. (2019). Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma. Medicine. 98(45). e17827–e17827. 5 indexed citations

12.

Huang, Tingxuan, et al.. (2018). Anaplastic plasmacytoma: report of one case and review of literature. 27(3). 183–186. 1 indexed citations

13.

Zheng, Jing, Tetsuya Asakawa, Yingyu Chen, et al.. (2017). Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells. Cellular Physiology and Biochemistry. 43(1). 419–430. 11 indexed citations

14.

Wang, Lingyan, et al.. (2014). Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling. Immunobiology. 220(3). 331–340. 24 indexed citations

15.

Chen, Yingyu, Jing Li, Jianda Hu, et al.. (2014). Emodin enhances ATRA-induced differentiation and induces apoptosis in acute myeloid leukemia cells. International Journal of Oncology. 45(5). 2076–2084. 22 indexed citations

16.

Hu, Jianda, et al.. (2013). Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells. Immunobiology. 218(9). 1147–1154. 13 indexed citations

17.

Hu, Jianda, et al.. (2013). [Expression and significance of stathmin1 in acute leukemia].. PubMed. 21(5). 1105–10. 2 indexed citations

18.

Zheng, Jing, et al.. (2012). Baicalin Induces Apoptosis in Leukemia HL-60/ADR Cells via Possible Down-regulation of the PI3K/Akt Signaling Pathway. Asian Pacific Journal of Cancer Prevention. 13(4). 1119–1124. 28 indexed citations

19.

Hu, Jianda, et al.. (2011). DIGE-based proteomic analysis identifies nucleophosmin/B23 and nucleolin C23 as over-expressed proteins in relapsed/refractory acute leukemia. Leukemia Research. 35(8). 1087–1092. 31 indexed citations

20.

Huang, Yi, et al.. (2008). Inhibition Effects of baicalin on Lymphoma Cell Line CA46 in Vitro and in Vivo. Blood. 112(11). 5053–5053. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact